Unconventional Developers Creating Vital Products

Biomedical asset development while helping to catalyze the formation of a thriving and sustainable life sciences entrepreneurship ecosystem for local and national markets.

Learn more

I am an investor interested in early-stage
biotech investing

Learn more

I am an early career scientist interested in product development

Opportunities

I am a university tech-transfer licensing manager interested in licensing
a technology

Licensing

What We Do

Fannin primarily in-licenses promising, early-stage therapeutic and medical device technologies from leading academic investigators in the Texas Medical Center and on a national stage.

Fannin develops and de-risks these technologies via preclinical work and engineering up through early clinical trials.

About

To develop early-stage pharmaceutical and medical device assets that address vital unmet medical needs.

Mission Statement

Robust Pipeline Across Programs

$242m+ Raised Via Grant And Investor Funding

300+ Interns And Fellows Trained

Testimonials

“Baylor College of Medicine values its strong relationship with Fannin Innovation Studio. The Fannin approach is particularly valuable in Houston biomedical commercialization ecosystem because it directly addresses the pressing need for more experienced entrepreneurial talent through its innovative internship program, which has served with ”real-world” product development experience.”
— Michael Dilling, PhD, Director, Baylor Licensing Group
“As the world’s leading cancer hospital, the research and clinical faculty at MD Anderson generates a remarkable breadth of basic sciences and clinical insights. Fannin provides unique approach to partnering with academic researchers to advance innovation, with the goal of helping shape the future of patient care.”
— Ronald A. DePinho, MD, Former President of MD Anderson Cancer Center